National Cancer Institute US. Fast Stats: esophagus cancer. 2008 [cited 15 July 2008]. Available from http://seer.cancer.gov/faststats/selections.php.
Bollschweiler E, Wolfgarten E, Gutschow C et al. Demographic variations in the rising incidence of esophageal adenocarcinoma in white males. Cancer 2001;92:549–555.
Lagergren J, Bergstrom R, Lindgren A et al. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999;340:825–831.
Farrow DC, Vaughan TL, Sweeney C et al. Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancer. Cancer Causes Control 2000;11:231–238.
Wu AH, Tseng CC, Bernstein L. Hiatal hernia, reflux symptoms, body size, and risk of esophageal and gastric adenocarcinoma. Cancer 2003;98:940–948.
Anderson LA, Watson RG, Murphy SJ et al. Risk factors for Barrett's oesophagus and oesophageal adenocarcinoma: results from the FINBAR study. World J Gastroenterol 2007;13:1585–1594.
Whiteman DC, Sadeghi S, Pandeya N et al. Combined effects of obesity, acid reflux and smoking on the risk of adenocarcinomas of the oesophagus. Gut 2008;57:173–180.
Portale G, Peters JH, Hagen JA et al. Comparison of the clinical and histological characteristics and survival of distal esophageal-gastroesophageal junction adenocarcinoma in patients with and without Barrett mucosa. Arch Surg 2005;140:570–574.
Sampliner RE. Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus. The Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol 1998;93:1028–1032.
Sampliner RE. Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus. Am J Gastroenterol 2002;97:1888–1895.
Armstrong D, Marshall JK, Chiba N et al. Canadian Consensus Conference on the management of gastroesophageal reflux disease in adults—update 2004. Can J Gastroenterol 2005;19:15–35.
Watson A, Heading RC, Shepherd NA. Guidelines for the diagnosis and management of Barrett's columnar-lined oesophagus. 2005 [cited 22 January 2007]. Available from http://www.bsg.org.uk/bsgdisp1.php?id=3f4a76385e42599499e9&h=1&sh=1&i=1&b=1&m=00023.
Wang KK, Wongkeesong M, Buttar NS. American Gastroenterological Association medical position statement: role of the gastroenterologist in the management of esophageal carcinoma. Gastroenterology 2005;128:1468–1470.
Wang KK, Sampliner RE. Practice parameters committee of the American college of G. Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus. Am J Gastroenterol 2008;103:788–797.
Calonge N (Ed). The Guide to clinical preventive services: recommendations of the US preventive services task force: agency for healthcare research and quality. US Department of Health and Human Services 2008, AHRQ Pub. No. 08-05122.
Rubenstein JH, Saini SD, Kuhn L et al. Influence of malpractice history on the practice of screening and surveillance for Barrett's esophagus. Am J Gastroenterol 2008;103:842–849.
Sato F, Jin Z, Schulmann K et al. Three-tiered risk stratification model to predict progression in Barrett's esophagus using epigenetic and clinical features. PLoS One 2008;3:e1890.
Kara MA, Ennahachi M, Fockens P et al. Detection and classification of the mucosal and vascular patterns (mucosal morphology) in Barrett's esophagus by using narrow band imaging. Gastrointest Endosc 2006;64:155–166.
Kara MA, Peters FP, Fockens P et al. Endoscopic video-autofluorescence imaging followed by narrow band imaging for detecting early neoplasia in Barrett's esophagus. Gastrointest Endosc 2006;64:176–185.
Shaheen NJ, Sharma P, Overholt BF et al. Radiofrequency ablation in Barrett's esophagus with dysplasia. N Engl J Med 2009;360:2277–2288.
Prasad GA, Wang KK, Buttar NS et al. Long-term survival following endoscopic and surgical treatment of high-grade dysplasia in Barrett's esophagus. Gastroenterology 2007;132:1226–1233.
Sox HC, Greenfield S. Initial National Priorities for Comparative Effectiveness Research, Institute of Medicine. The National Academies Press: Washington, DC, 2009. Available from: http://www.nap.edu/catalog.php?record_id=12648.
El-Serag HB. Time trends of gastroesophageal reflux disease: a systematic review. Clin Gastroenterol Hepatol 2007;5:17–26.
Rubenstein JH, Taylor JB. Meta-analysis: the association of oesophageal adenocarcinoma with symptoms of gastro-oesophageal reflux. Aliment Pharmacol Ther 2010;32:1222–1227.
Kung H-C, Hoyert DL, Xu J et al. National vital statistics reports. Deaths: Final Data for 2005 2008;56.
Surveillance, Epidemiology, and End Results (SEER) Program ( http://www.seer.cancer.gov ) SEER*Stat Database: Populations - Total US (1990–2005) 〈Single Ages to 85+, Katrina/Rita Adjustment〉 - Linked To County Attributes - Total US, 1969–2005 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released February 2008. In: National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch; Released February 2008.
Surveillance, Epidemiology, and End Results (SEER) Program ( http://www.seer.cancer.gov ) SEER*Stat Database: Incidence - SEER 17 Regs Limited-Use + Hurricane Katrina Impacted Louisiana Cases, Nov 2007 Sub (2000–2005) 〈Katrina/Rita Population Adjustment〉 - Linked To County Attributes - Total US, 1969–2005 Counties. In: National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch; Released April 2008, based on the November 2007 submission..
El-Serag HB, Petersen NJ, Carter J et al. Gastroesophageal reflux among different racial groups in the United States. Gastroenterology 2004;126:1692–1699.
NHS Cancer Screening Programmes 9 March 2010. Available from: http://www.cancerscreening.nhs.uk/.
Rubenstein JH, Sonnenberg A, Davis J et al. Effect of a prior endoscopy on outcomes of esophageal adenocarcinoma among United States veterans. Gastrointest Endosc 2008;68:849–855.
Sharma P, McQuaid K, Dent J et al. A critical review of the diagnosis and management of Barrett's esophagus: the AGA Chicago workshop. Gastroenterology 2004;127:310–330.
Cooper GS, Kou TD, Chak A. Receipt of previous diagnoses and endoscopy and outcome from esophageal adenocarcinoma: a population-based study with temporal trends. Am J Gastroenterol 2009;104:1356.
Cooper GS, Yuan Z, Chak A et al. Association of prediagnosis endoscopy with stage and survival in adenocarcinoma of the esophagus and gastric cardia. Cancer 2002;95:32–38.
Corley DA, Levin TR, Habel LA et al. Surveillance and survival in Barrett's adenocarcinomas: a population-based study. Gastroenterology 2002;122:633–640.
Reyna VF, Reyna VF. A theory of medical decision making and health: fuzzy trace theory. Med Decis Making 2008;28:850–865.
Lagergren J, Ye W, Bergstrom R et al. Utility of endoscopic screening for upper gastrointestinal adenocarcinoma. JAMA 2000;284:961–962.
Locke III GR, Talley NJ, Fett SL et al. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 1997;112:1448–1456.
Eslick GD, Talley NJ. Gastroesophageal reflux disease (GERD): risk factors, and impact on quality of life-a population-based study. J Clin Gastroenterol 2009;43:111–117.
Nilsson M, Johnsen R, Ye W et al. Prevalence of gastro-oesophageal reflux symptoms and the influence of age and sex. Scand J Gastroenterol 2004;39:1040–1045.
Carney PA, Miglioretti DL, Yankaskas BC et al. Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. [erratum appears in Ann Intern Med 2003;138(9):771] Ann Intern Med 2003;138:168–175.